Sanguisorba officinalis extract, ziyuglycoside I, and II exhibit antiviral effects against hepatitis B virus
Conclusion Taken together, SOE noticeably inhibited replication and antigen secretion of HBV, which was at least in part attributed to ziyuglycoside II, thus presenting the possibility of developing therapeutic candidates for the treatment of HBV-related diseases.
Source: European Journal of Integrative Medicine - Category: Complementary Medicine Source Type: research
More News: Burns | China Health | Complementary Medicine | Dermatitis | Dermatology | Hepatitis | Hepatitis B | Japan Health | Study